Table of Contents
Washington University Experience | MYELIN (IMMUNE-MEDIATED) | Sentinel & Steroid Rx Lesions | 4H1 Lymphoma, B cell & sentinel (Case 4) 2X Ki67
4H1,2 The proliferative activity differences are evident with Ki67 immunohistochemistry, with high levels in the tumor rich region and very limited numbers in the demyelinative ones. (Ki67 IHC)
